Amphastar Pharmaceuticals, Inc. (AMPH)

Nasdaq: AMPH · Pharmaceutical Preparations · Rancho Cucamonga, CA · filing with the SEC since 2005

Grade6.5

◀ Past 7.8● Present 7.4▶ Future 4.1

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 26, 2026	Mar 3, 2025	Feb 29, 2024	Mar 1, 2023	Mar 11, 2022	Mar 15, 2021	Mar 16, 2020	Mar 15, 2019	Mar 14, 2018	Mar 15, 2017
Revenue	719,887	731,967	644,395	498,987	437,768	349,846	322,357	294,666	240,175	255,165
Cost of revenue	363,830	358,112	293,274	250,127	238,029	206,506	190,434	187,681	149,666^r	150,969^r
Gross profit	356,057	373,855	351,121	248,860	199,739	143,340	131,923	106,985	90,509^r	104,196^r
Research and development	85,844	73,914	73,741	74,771	60,932	67,229	68,853	57,564	43,503^r	41,522^r
Sales and marketing	43,885	37,802	28,853	21,531	17,486	14,780	12,830	8,156	6,460	5,466
General and administrative	85,925	56,720	51,540	45,061	51,434	50,377	50,279	49,888	44,458	41,832
Total operating expenses	215,654	168,436	154,134	141,363	129,852	132,386	131,962	115,608	91,778^r	88,820^r
Operating income	140,403	205,419	196,987	107,497	69,887	10,954	-39	-8,623	-1,269^r	15,376^r
Interest expense	25,481	30,343	27,158	1,846	885	374	119	243	826	1,024
Interest and investment income	8,679	10,612	5,459	1,321	601	642	997	456	425	270
Share of profit of equity-method investments	·	-573	-1,981	-1,177	-208	·	·	·	·	·
Other income (expense), net	23	4,076	-3,929	9,068	14,536	-6,585	59,389	-1,516	2,919	8
Total non-operating income (expense)	-16,779	-15,655	-25,628	8,543	14,252	-6,317	60,267	-1,303	2,518	-746
Income before income taxes	123,624	189,764	171,359	116,040	84,139	4,637	60,228	-9,926	1,249^r	14,630^r
Income tax expense	25,530	29,672	31,833	23,477	20,630	3,540	13,723	-3,266	-2,398^r	4,810^r
Net income including non-controlling interests	98,094	159,519	137,545	91,386	63,301	1,097	46,505	-6,660	3,647	9,820
Net income to non-controlling interests	·	·	·	·	1,185	-306	-2,434	-922	·	·
Net income	98,094	159,519	137,545	91,386	62,116	1,403	48,939	-5,738	3,647^r	9,820^r
Earnings per share, basic	2.10	3.29	2.85	1.88	1.30	0.03	1.04	-0.12	0.08^r	0.22^r
Earnings per share, diluted	2.03	3.06	2.60	1.74	1.25	0.03	0.98	-0.12	0.08^r	0.21^r
Weighted average shares, basic	46,743	48,429	48,265	48,551	47,777	47,038	46,982	46,395	46,107	45,375
Weighted average shares, diluted	48,215	52,058	53,001	52,427	49,784	49,124	49,907	46,395	48,367	47,504

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:Revenues
us-gaap:SalesRevenueNet

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton AMPH · research, not advice